jeudi 28 mars 2019

Onco Actu du 28 mars 2019


1. BIOLOGIE



New potential therapeutic target for pancreatic cancer discovered [MD Anderson Cancer Center]











2.10 ETIOLOGIE - ALCOOL



A bottle of wine a week could increase women’s cancer risk as much as smoking 10 cigarettes [The Telegraph]











How many cigarettes in a bottle of wine? [BBC News]










2.6 ETIOLOGIE - ENVIRONNEMENT



U.S. jury says Bayer must pay $80 million to man in Roundup cancer trial [Reuters]











Monsanto Ordered to Pay $80 Million in Roundup Cancer Case [NY Times]










3.1 PRÉVENTION - TABAC



Keep out of reach of children—the case for increasing the legal age for tobacco purchase to 21 [BMJ]











3.3 PRÉVENTION - VACCINS



Japanese journalist found guilty of defamation in HPV vaccine case [Science]











4.5 DÉP., DIAG. & PRONO. - COLORECTAL



Proceed with caution before changing colonoscopy recommendations, Stanford physician urges [Stanford Medicine]










4.9 DÉP., DIAG. & PRONO. - SEIN



FDA advances landmark policy changes to modernize mammography services and improve their quality [FDA]










FDA proposes mammography rule to provide women with breast-density information [Washington Post]











Dense breast notification laws tied to more screening, cancer diagnoses [Reuters]











Mammogram Centers Must Tell Women if They Have Dense Breasts, F.D.A. Proposes [NY Times]











5. TRAITEMENTS



Can proton therapy be considered a standard of care in oncology? Lessons from the United States [British Journal Of Cancer]










5.1 TRAITEMENTS - PRÉ-CLINIQUE



Low-dose radiation therapy improves delivery of therapeutic nanoparticles to brain tumors [Mass. General Hospital]











5.10 TRAITEMENTS - ESSAIS



Trial Examines Value of Lymph Node Surgery in Advanced Ovarian Cancer [NCI]










Low risk pragmatic trials do not always require participants’ informed consent [BMJ]











5.12 IMMUNOTHÉRAPIES



Glowing Tumors Show Scientists Where Cancer Drugs Are Working [Johns Hopkins]











5.12.1 IMMUNOTHÉRAPIES - PARTENARIATS



Ono pumps cash into U.K. immuno-oncology R&D effort [Fierce Biotech]











Cancer Research UK, LifeArc and Ono Pharma form cancer immunotherapy alliance [Cancer Research UK]











OSE Immunotherapeutics Announces New Research Collaboration with Léon Bérard Cancer Center to Use Artificial Intelligence Technologies to Identify Novel Immuno-Oncology Targets [OSE]











5.3 TRAITEMENTS - FDA, EMA, NICE...



FDA’s Oncology Center of Excellence touts 2018 accomplishments [EndPoints]











5.4 TRAITEMENTS - ECONOMIE



Building on the first 20 years: the NICE Connect project Professor Gillian Leng, deputy chief executive and director of health and social care at NICE [NICE]











5.9 AACR



NanoString Highlights Record Number of nCounter and GeoMx Research Studies at 2019 American Association of Cancer Research (AACR) Conference [NanoString]











Bayer to showcase latest oncology research at AACR 2019 underscoring its commitment to advancing the future of cancer care [Bayer]











5.9.12 AACR - BIOPSIES LIQUIDES



Caris Life Sciences to Present Initial Study Results for Blood-Based Prostate Cancer Test at AACR Annual Meeting [Caris]











Resolution Liquid Biopsy Assay Detects More Actionable Oncogenic Fusions with Higher Allele Frequency than Guardant360 [Resolution Bioscience]











6. LUTTE CONTRE LES CANCERS



Recent Advances in Colorectal Cancer Research [Cancer Research Catalyst]











6.4 MÉDICO-ÉCO



U-turn over plans to privatise cancer scanning services [The Guardian]











6.6 PUBLICATIONS



Plagiarism detectors are a crutch, and a problem [Nature]











6.7.1 IA/BIOINFORMATIQUE



As AI permeates clinical analytics, Perceptive Advisors bets $40M into a storied player in the field [EndPoints]











‘Godfathers of AI’ honored with Turing Award, the Nobel Prize of computing [The Verge]











6.9 CONTROVERSES



Weeks after California loss, J&J scores talc victory close to home [Fierce Pharma]











New Jersey jury finds J&J not liable in talc cancer trial; company settles three other cases [Reuters]











Johnson & Johnson Cleared by New Jersey Jury in Latest Talc Cancer Trial [NY Times]